Search
Zhejiang Shuwen Biotechnology Co., Ltd. has recently announced the successful completion of its C1 funding round, raising nearly 100 million yuan, and the commencement of its C2 funding round. This latest round of funding was led by Jinchuangtou, with additional contributions from existing shareholder Yuansheng Venture Capital. The proceeds will be allocated towards accelerating the market penetration of the company's globally pioneering diagnostic products, bolstering investment in new product research and development, and enhancing the product portfolio for precision diagnosis and treatment in women's health. Shuwen Biotechnology specializes in the development, production, and distribution of in vitro diagnostic reagents tailored to women's health, striving to advance the field of women's health diagnostics.
-
C114 Communication Network -
Communication Home
